Third Quarter 2015 Consolidated Pro Forma Highlights: Consolidated pro forma revenue increased 6.5% to $20.9 million from $19.6 million in the third quarter of 2014.  Excluding OEM revenue, third quarter 2015 consolidated pro forma revenue increased 13.8% to $20.2 million from $17.7 million in the

BELGRADE, Mont., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the first surgical implantation of OsteoSelect PLUS Demineralized Bone Matrix (DBM) Putty, developed by

BELGRADE, Mont., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE: XTNT ), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the period ended September 30, 2015, at the close of the

BELGRADE, Mont., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSEMKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its common stock will begin trading today on the NYSE MKT under the symbol "XTNT." About Xtant

BELGRADE, Mont. , Oct. 15, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its common stock has been approved for listing on the NYSE MKT.

Third Quarter 2015 Pro Forma Combined Revenue in the range of $20.7 million to $20.9 million , an increase of 5.5 % to 6.5 % over the same period last year Excluding OEM Revenue, Third Quarter 2015 Pro Forma Combined Revenue expected to increase between 12.7% to 13.8% compared to last year

BELGRADE, Mont. , Oct. 12, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiaries, X-spine Systems Inc. and Bacterin International, Inc.

BELGRADE, Mont. , Oct. 06, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, Bacterin International, Inc.

BELGRADE, Mont. , Sept. 28, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiaries, X-spine Systems and Bacterin International will be attending the

BELGRADE, Mont. , Sept. 22, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, Bacterin International, Inc.